Sample | Title | Value | Rank |
GSM780707 | Untreated after 4 days (C1_1) | 70.4398 | 69 |
GSM780708 | Untreated after 4 days (C2_1) | 89.8876 | 74 |
GSM780709 | Untreated after 4 days (C3_1) | 70.3269 | 69 |
GSM780719 | Untreated after 4 days (C1_2) | 74.3447 | 70 |
GSM780720 | Untreated after 4 days (C2_2) | 88.2506 | 73 |
GSM780721 | Untreated after 4 days (C3_2) | 71.4245 | 69 |
GSM780710 | Trastuzumab treated after 4 days (T1_1) | 72.0297 | 70 |
GSM780711 | Trastuzumab treated after 4 days (T2_1) | 90.9838 | 74 |
GSM780712 | Trastuzumab treated after 4 days (T3_1) | 68.5901 | 69 |
GSM780722 | Trastuzumab treated after 4 days (T1_2) | 68.8456 | 69 |
GSM780723 | Trastuzumab treated after 4 days (T2_2) | 91.1671 | 74 |
GSM780724 | Trastuzumab treated after 4 days (T3_2) | 60.3769 | 65 |
GSM780713 | Pertuzumab treated after 4 days (P1_1) | 108.197 | 76 |
GSM780714 | Pertuzumab treated after 4 days (P2_1) | 79.6688 | 72 |
GSM780715 | Pertuzumab treated after 4 days (P3_1) | 75.7429 | 71 |
GSM780725 | Pertuzumab treated after 4 days (P1_2) | 101.84 | 75 |
GSM780726 | Pertuzumab treated after 4 days (P2_2) | 80.1264 | 72 |
GSM780727 | Pertuzumab treated after 4 days (P3_2) | 69.7104 | 69 |
GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 53.4954 | 57 |
GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 42.4424 | 15 |
GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 51.5679 | 53 |
GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 54.0896 | 58 |
GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 58.8672 | 64 |